#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenocortical carcinoma Leiomyosarcoma metastatic Sarcoma Anti-myelin-associated glycoprotein antibodies positive Diffuse large B-cell lymphoma recurrent Marginal zone lymphoma refractory Short-bowel syndrome Extranodal marginal zone B-cell lymphoma (MALT type) Pituitary-dependent Cushing's syndrome Dedifferentiated liposarcoma Osteosarcoma Juvenile chronic myelomonocytic leukaemia Systemic scleroderma HER2 gene amplification Epilepsy More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia – Trials in Disease Alveolar rhabdomyosarcoma – Trials in Disease Myelodysplastic syndrome with excess blasts – Trials in Disease Antisynthetase syndrome – Trials in Disease Primary mediastinal large B-cell lymphoma – Trials in Disease Alternating hemiplegia of childhood – Diagnostics Combined immunodeficiency – Diagnostics Chondrosarcoma metastatic – Trials in Disease Langerhans cell sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Repagermanium Umeclidinium Andexanet Alfa ULEFNERSEN Esomeprazole Magnesium Mexiletine Nanatinostat Alanine Calcipotriol Amoxicillin Sodium Iptacopan Acetylsalicylic Acid Ph. Eur. Betibeglogene Autotemcel Iron Sucrose Follitropin Alfa MB-001 L-METHIONINE Allo-501A Anb032 AGA2118 More therapies…

    Learn about Your Condition

    Ovarian granulosa cell tumour Asplenia Oesophageal adenocarcinoma Abdominal pain Hyperhidrosis Dupuytren's contracture Epidermolysis bullosa Neurotrophic keratopathy Acoustic neuroma Schizophrenia Skin ulcer Small intestine carcinoma Metastatic gastric cancer Propionic acidaemia Atrophic vulvovaginitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Moxifloxacin for Treating Uncomplicated Acute Appendicitis in Adults

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Moxifloxacin
    Finland

  • Study Comparing Sodium Chloride and Lactated Ringer’s Solution for Patients with Acute Pancreatitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatitis acute
    Investigated Drugs:
    • Sodium Lactate Solution
    • Calcium Chloride Dihydrate
    • Potassium Chloride
    France Spain

  • Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Belgium Denmark Germany Hungary The Netherlands Spain

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain
Previous Page
1 … 55 56 57 58 59 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!